Search PubMed⌕ Search

PubMed · 8798167

A generic genetic algorithm for generating beam weights.

Abstract

A genetic algorithm for generating beam weights is described. The algorithm improves an objective measure of the dose distribution while respecting dose volume constraints placed on critical structures. The algorithm was used to select beam weights for treatment of abdominal tumors. Weights were selected for up to 36 beams. Dose volume limits were placed on normal organs and a dose inhomogeneity limit was placed on tumor. Volumes were represented as sets of several hundred discrete points. The algorithm searched for the beam weights that would make the minimum tumor dose as high as the constraints would allow. The results were checked using dose volume histograms with standard sized grids. Nineteen trials were created using six patient cases by changing the required field margin or allowed beam position in each case. The sampling of points was sufficiently dense to yield solutions that strictly satisfied the constraints when the prescribed dose was renormalized by a factor of less than 6%. The genetic algorithm supplied solutions in 49 min on average, and in a maximum time of 87 min. The randomized search does not guarantee optimality, but high tumor doses were obtained. An example is shown for which the solution of the genetic algorithm gave a minimum tumor dose 7 Gy higher than the solution given by a simulated annealing algorithm under the same set of constraints. The genetic algorithm can be generalized to admit nonlinear functions of the beam intensities in the objective or in the constraints. These can include tumor control and normal tissue complication probabilities. The genetic algorithm is an attractive procedure for assigning beam weights in multifield plans. It improves the dose distribution while respecting specified rules for tissue tolerance.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Langer, R Brown, S Morrill, R Lane, O Lee. 1996. A generic genetic algorithm for generating beam weights.. https://doi.org/10.1118/1.597858. https://searchpubmed.org/record/pubmed%3A8798167/a-generic-genetic-algorithm-for-generating-beam-weights

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related citations

Sister Mary Joseph's nodule as presenting sign of a desmoplastic small round cell tumor.

Umbilical metastases, also named Sister Mary Joseph's nodules, are well documented in the adult population and most often represent an underlying intra-abdominal malignancy, usually a carcinoma of gastrointestinal or gynecologic origin. They are indicative of widespread abdominal disease and are associated with a poor prognosis. An extensive review of the literature reveals only two such presentations in the pediatric population. A 14-year-old male presented with an umbilical mass, which was found to be a metastatic lesion of a desmoplastic small round cell tumor (DSRCT) of the abdomen. The diagnosis of an intra-abdominal malignancy, most commonly a DSRCT, should be considered in the presence of an umbilical mass in a child.

Abdominal Neoplasms↗

Cytology of desmoplastic small round-cell tumor: comparison of pre- and post-chemotherapy fine-needle aspiration biopsies.

BACKGROUND: Desmoplastic small round-cell tumor (DSRCT) is an aggressive malignancy of young adults, which is amenable to fine-needle aspiration biopsy (FNAB). As this entity is increasingly recognized and biopsied, cytopathologists are compelled to become familiar with the range of cytologic features of DSRCT. In addition, postchemotherapy tumors may be sampled to confirm disease recurrence before planning additional therapy. This study was designed to compare prechemotherapy and postchemotherapy cytomorphology of DSRCT and to evaluate for distinct chemotherapy-induced changes. METHODS: The authors searched their respective institutional databases for all DSRCT cases with an associated FNAB. FNAB slides, immunocytochemistry, and cytogenetic results were reviewed. RESULTS: Six aspirates from 5 patients were identified, 3 of which were postchemotherapy. The postchemotherapy cases demonstrated cytologic findings not typically described in DSRCTs, including prominent and conspicuous nucleoli, discohesive single-cell architecture, and slightly larger cell size. CONCLUSIONS: Cytomorphologic variability was prominent in prechemotherapy cases, and no case could be classified as DSRCT on cytology alone; immunohistochemistry was necessary for definitive diagnosis. Chemotherapy increased the spectrum of cytologic features. The most notable difference between the 2 groups was a predominantly discohesive single-cell pattern with conspicuous nucleoli in the postchemotherapy group, instead of the clustering pattern of medium-sized cells with inconspicuous nucleoli typically attributed to de novo cases reported in the literature.

Abdominal Neoplasms↗